...
首页> 外文期刊>Emerging Infectious Diseases >Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea
【24h】

Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea

机译:联合使用洛哌丁胺和抗菌药物治疗旅行者腹泻的产ESBL细菌的风险增加

获取原文

摘要

Antimicrobial drug treatment of travelers’ diarrhea is known to increase the risk for colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae . Among 288 travelers with travelers’ diarrhea, the colonization rate without medications was 21%. For treatment with loperamide only, the rate was 20%; with antimicrobial drugs alone, 40%; and with loperamide and antimicrobial drugs, 71%.
机译:已知旅行者腹泻的抗菌药物治疗会增加产生广谱β-内酰胺酶的肠杆菌科细菌定植的风险。在288名有腹泻的旅客中,未使用药物的定植率为21%。仅使用洛哌丁胺治疗的比例为20%。仅使用抗菌药物的占40%;以及洛哌丁胺和抗菌药物的比例为71%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号